Sažetak sa skupa

Auto-Medication of Analgesics by Dental Patients

Ileana Linčir
Kata Rošin-Grget
Ivana Šutej

Sažetak

Pain is one of the major challenges in dental care. The most common types of odontogenic pain are characterised as acute pain which is frequently associated with selfmedication with analgesics. However , there is a risk with self-medication such as the use of excessive drug dosage, prolonged duration of use, clinically significant interactions with prescription medicines and polypharmacy and possible side effects. The initial event for most painful conditions is a noxious stimulus that results in tissue destruction, the synthesis and the release of biochemical mediators involved in the pain process. Peripherally acting nonsteroid analgesic-antipyretic drugs /NSAIDs/ are the most commonly used analgesics. They inhibit these biochemical mediators of pain. All NSAIDs share a qualitatively similar side ellect profile, the oral route of administration and all of them are freely available to the general public without prescription over the counter drugs (OTC).
The aim of this study was to determine the incidence of auto medication with analgesics among dental patients with acute pain. 32 patients aged from 19 to 73 years, (32.5) of both sexes and with odontalgia were interviewed personally regarding the intensity of their pre-treatment pain and the use of medications. 68% of patients described their pain as severe, 21.9% as moderate pin and 10.1% as unpleasant sensation. The results showed that 99.6% of the patients self-medicated a drug for the immediate relief of toothache. The most frequently self-medicated analgesics were: analgesic-atipyretic combined formulations (propiphenazon + paracetamol + coffeine + codeine) in 33% and diclofenac (Voltaren) in 29.1%, the metamizol in 21.8%, aspirin in 13% and ibuprofen in 3.1%. Selfmedicated drugs came from the pharmacist in 56% patients and 44% from the family stock. Patients (87.5%) were well informed about possible side effects and toxicity of NSAIDs. Adverse effects during therapy was reported by 21.8% patients, mainly as gastrointestinal symptoms: nausea and gastric pain. This is in egreement with the wel documented NSAIDs side effects which are presumably the result of inhibiting cyclooxygenases and a significant cause of morbidity.

Ključne riječi

Hrčak ID:

3435

URI

https://hrcak.srce.hr/3435

Datum izdavanja:

15.9.2003.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.207 *